(Q53226841)

12 May 2018

title

Apolipoprotein E epsilon 4, other risk factors, and course of Alzheimer's disease. (English)

1 reference

12 May 2018

author

Myron F. Weiner

1

1 reference

12 May 2018

author name string

Vega G

2

1 reference

12 May 2018

Risser RC

3

1 reference

12 May 2018

Honig LS

4

1 reference

12 May 2018

Cullum CM

5

1 reference

12 May 2018

Crumpacker D

6

1 reference

12 May 2018

Rosenberg RN

7

1 reference

12 May 2018

language of work or name

English

0 references

publication date

1 March 1999

1 reference

12 May 2018

published in

Biological Psychiatry

1 reference

12 May 2018

volume

45

1 reference

12 May 2018

issue

5

1 reference

12 May 2018

page(s)

633-638

1 reference

12 May 2018

ApoE-4 and age at onset of Alzheimer's disease: the NIMH genetics initiative.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900222-4

The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900222-4

A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900222-4

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900222-4

Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900222-4

Apolipoprotein E polymorphism and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900222-4

Alzheimer's disease: interaction of apolipoprotein E genotype, family history of dementia, gender, education, ethnicity, and age of onset.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900222-4

Genotyping and sequence analysis of apolipoprotein E isoforms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900222-4

Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900222-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900222-4

Alzheimer's disease with and without coexisting Parkinson's disease changes: apolipoprotein E genotype and neuropathologic correlates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900222-4

Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900222-4

The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900222-4

Senile dementia of the Lewy body type has an apolipoprotein E epsilon 4 allele frequency intermediate between controls and Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900222-4

Apolipoprotein E epsilon 4 allele, cognitive decline, and deterioration of everyday performance in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900222-4

The apolipoprotein E epsilon 4 allele is not associated with psychiatric symptoms or extrapyramidal signs in probable Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900222-4

Apolipoprotein E: cholesterol transport protein with expanding role in cell biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900222-4

Synergistic effects of traumatic head injury and apolipoprotein-epsilon 4 in patients with Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900222-4

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900222-4

No association between apolipoprotein E epsilon 4 allele and rate of decline in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900222-4

Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900222-4

Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900222-4

Apolipoprotein E epsilon 4 allele is associated with deposition of amyloid beta-protein following head injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900222-4

The impact of apolipoprotein E4 on cause of death in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900222-4

Head injury and risk of Alzheimer's disease by apolipoprotein E genotype.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900222-4

Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900222-4

Apolipoprotein E epsilon 4 allele and the lifetime risk of Alzheimer's disease. What physicians know, and what they should know.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900222-4

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900222-4

Alzheimer's disease and its Lewy body variant: a clinical analysis of postmortem verified cases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900222-4

Apolipoprotein E phenotype and cognitive decline in a prospective study of elderly community women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900222-4

10.1016/S0006-3223(98)00222-4

7 January 2021

Identifiers

DOI

1 reference

12 May 2018

PubMed ID

10088051

1 reference

12 May 2018